{"id":"W3160261501","doi":"10.1007/s40273-021-01028-3","title":"Cost Effectiveness of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Pre-/Perimenopausal, HR+ and HER2− Advanced Breast Cancer: A Canadian Healthcare Perspective","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Breast cancer; Quality-adjusted life year; Tamoxifen; Discontinuation; Aromatase inhibitor; Cost effectiveness; Internal medicine; Oncology; Cost-effectiveness analysis; Health economics; Gynecology; Hazard ratio; Cancer; Public health; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020621,0.0002823113,0.0006922943,0.0001960725,0.00007347887,0.00002047051,0.00009140783,0.00008893911,0.00009950675],"category_scores_gemma":[0.00002214965,0.0003227423,0.00006040718,0.0002221705,0.0001703333,0.0002829045,0.00006644679,0.0003329926,0.000005116569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002730134,"about_ca_system_score_gemma":0.002630457,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07516361,"about_ca_topic_score_gemma":0.08030609,"domain_scores_codex":[0.9983183,0.0001484839,0.0003828201,0.0005741424,0.00009467251,0.000481585],"domain_scores_gemma":[0.9987265,0.0001284826,0.0001482064,0.0002706889,0.0002277182,0.0004983356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03937608,0.001326852,0.2498177,0.005839827,0.001793074,0.001535749,0.01951557,0.008115441,0.5279966,0.002109224,0.000185286,0.1423886],"study_design_scores_gemma":[0.06347408,0.000914296,0.4898679,0.003661014,0.0004499546,0.00312469,0.0113431,0.00360046,0.4129245,0.0009161267,0.007833419,0.001890462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985506,0.007833676,0.00002397812,0.002866125,0.0003164701,0.001134369,0.002183878,0.00003245006,0.0001030324],"genre_scores_gemma":[0.9971935,0.0008734523,0.0004149324,0.0008989357,0.0001530586,0.0002847135,0.00009669834,0.00006115026,0.00002360473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2400502,"threshold_uncertainty_score":0.9999225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02113951258208011,"score_gpt":0.3660010550140271,"score_spread":0.3448615424319469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}